Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-12

FDA Approved: PREGABALIN — Original Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Cadila Pharmaceuticals Limited's original application for pregabalin, enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)